Evidence map›Paper›PMID 34580193›Full record

Observational studyThorax2022

Smoking and COVID-19 outcomes: an observational and Mendelian randomisation study using the UK Biobank cohort.

Ashley K Clift, Adam von Ende, Pui San Tan, Hannah M Sallis, Nicola Lindson, Carol A C Coupland, Marcus R Munafò, Paul Aveyard, Julia Hippisley-Cox, Jemma C Hopewell

Abstract readObservational Study
In one paragraph

Observational study in Thorax, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 109 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
109citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

109 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. The role of smoking in COVID-19 progression: a comprehensive meta-analysis.European respiratory review : an official journal of the European Respiratory Society · 2023
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Sex Differences and Clinical Outcomes of Patients with Coronavirus Disease 2019 Infection and Cerebral Venous Sinus Thrombosis: A Systematic Review.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Pooled it
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

49 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Ashley K CliftNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK ashley.clift@phc.ox.ac.uk.ORCID 0000-0002-0061-979X
Adam von EndeClinical Trial Service Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.ORCID 0000-0003-0000-5664
Pui San TanNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Hannah M SallisMRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
Nicola LindsonNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Carol A C CouplandNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Marcus R MunafòMRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
Paul AveyardNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.ORCID 0000-0002-1802-4217
Julia Hippisley-CoxNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Jemma C HopewellClinical Trial Service Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.ORCID 0000-0002-3870-8018

Funding

British Heart Foundation FS/14/55/30806Cancer Research UK 16896European Research CouncilMedical Research Council MC_PC_17228Medical Research Council MC_QA137853Medical Research Council MC_UU_00011/7
6 · The paper itself

Abstract

backgroundConflicting evidence has emerged regarding the relevance of smoking on risk of COVID-19 and its severity.

methodsWe undertook large-scale observational and Mendelian randomisation (MR) analyses using UK Biobank. Most recent smoking status was determined from primary care records (70.8%) and UK Biobank questionnaire data (29.2%). COVID-19 outcomes were derived from Public Health England SARS-CoV-2 testing data, hospital admissions data, and death certificates (until 18 August 2020). Logistic regression was used to estimate associations between smoking status and confirmed SARS-CoV-2 infection, COVID-19-related hospitalisation, and COVID-19-related death. Inverse variance-weighted MR analyses using established genetic instruments for smoking initiation and smoking heaviness were undertaken (reported per SD increase).

resultsThere were 421 469 eligible participants, 1649 confirmed infections, 968 COVID-19-related hospitalisations and 444 COVID-19-related deaths. Compared with never-smokers, current smokers had higher risks of hospitalisation (OR 1.80, 95% CI 1.26 to 2.29) and mortality (smoking 1-9/day: OR 2.14, 95% CI 0.87 to 5.24; 10-19/day: OR 5.91, 95% CI 3.66 to 9.54; 20+/day: OR 6.11, 95% CI 3.59 to 10.42). In MR analyses of 281 105 White British participants, genetically predicted propensity to initiate smoking was associated with higher risks of infection (OR 1.45, 95% CI 1.10 to 1.91) and hospitalisation (OR 1.60, 95% CI 1.13 to 2.27). Genetically predicted higher number of cigarettes smoked per day was associated with higher risks of all outcomes (infection OR 2.51, 95% CI 1.20 to 5.24; hospitalisation OR 5.08, 95% CI 2.04 to 12.66; and death OR 10.02, 95% CI 2.53 to 39.72).

interpretationCongruent results from two analytical approaches support a causal effect of smoking on risk of severe COVID-19.

Indexed as

COVID-19Biological Specimen BanksCOVID-19 TestingEnglandHumansSARS-CoV-2Smokingclinical epidemiologyCOVID-19tobacco control

Identifiers

PMID34580193
PMCPMC8483921

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.